Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor

Hiroyuki Takemura, Hiroshi Suzuki, Hiroshi Fujisawa, Takamichi Yuhara, Takao Akama, Kazuhide Yamane, Hachiro Kashiwagi

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Objective. The pathophysiology of systemic sclerosis (SSc) is poorly understood, but recent studies indicate the involvement of cytokines in the functional changes of SSc fibroblasts. We investigated interleukin 6 (IL-6) production by dermal fibroblasts from patients with SSc. Methods. Fibroblast cultures were established from affected skin of patients with SSc and from skin of healthy controls. IL-6 in supernatants from cultured fibroblasts was measured using a specific IL-6 ELISA. Results. SSc fibroblasts, starved in serum-free medium, produced only a small amount of IL-6. However, IL-6 production by SSc fibroblasts dramatically increased when the cells were cultured in serum-containing medium. Human whole blood serum was more effective than human platelet-poor plasma derived serum in the enhancement of IL-6 production by SSc fibroblasts. Platelet derived growth factor (PDGF)-AA and PDGF-BB, a major growth factor in serum, induced significant IL-6 production by SSc fibroblasts. In contrast, in normal fibroblasts, much less response to PDGF-BB and almost no response to PDGF-AA were observed. Expression of PDGF receptors on SSc fibroblasts was not significantly different from normal fibroblasts. However, IL-1 receptor antagonist (IL- 1ra), when added in the medium, significantly inhibited the PDGF-induced IL- 6 production by SSc fibroblasts. Conclusion. PDGF stimulates IL-6 production by SSc fibroblasts. The enhanced IL-6 production in response to PDGF is due in part to autocrine IL-1 of SSc fibroblasts. These abnormalities of fibroblasts may play an important role in the inflammatory and immunological processes of SSc.

Original languageEnglish
Pages (from-to)1534-1539
Number of pages6
JournalJournal of Rheumatology
Volume25
Issue number8
Publication statusPublished - 1998 Aug
Externally publishedYes

Fingerprint

Systemic Scleroderma
Platelet-Derived Growth Factor
Interleukin-6
Fibroblasts
Serum
Skin
Platelet-Derived Growth Factor Receptors
Interleukin-1 Receptors
Serum-Free Culture Media
Interleukin-1

Keywords

  • Fibroblast
  • Interleukin 6
  • Platelet derived growth factor
  • Scleroderma

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor. / Takemura, Hiroyuki; Suzuki, Hiroshi; Fujisawa, Hiroshi; Yuhara, Takamichi; Akama, Takao; Yamane, Kazuhide; Kashiwagi, Hachiro.

In: Journal of Rheumatology, Vol. 25, No. 8, 08.1998, p. 1534-1539.

Research output: Contribution to journalArticle

Takemura, Hiroyuki ; Suzuki, Hiroshi ; Fujisawa, Hiroshi ; Yuhara, Takamichi ; Akama, Takao ; Yamane, Kazuhide ; Kashiwagi, Hachiro. / Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor. In: Journal of Rheumatology. 1998 ; Vol. 25, No. 8. pp. 1534-1539.
@article{d7a0f4e628894e6a8bcbd965a0a91d51,
title = "Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor",
abstract = "Objective. The pathophysiology of systemic sclerosis (SSc) is poorly understood, but recent studies indicate the involvement of cytokines in the functional changes of SSc fibroblasts. We investigated interleukin 6 (IL-6) production by dermal fibroblasts from patients with SSc. Methods. Fibroblast cultures were established from affected skin of patients with SSc and from skin of healthy controls. IL-6 in supernatants from cultured fibroblasts was measured using a specific IL-6 ELISA. Results. SSc fibroblasts, starved in serum-free medium, produced only a small amount of IL-6. However, IL-6 production by SSc fibroblasts dramatically increased when the cells were cultured in serum-containing medium. Human whole blood serum was more effective than human platelet-poor plasma derived serum in the enhancement of IL-6 production by SSc fibroblasts. Platelet derived growth factor (PDGF)-AA and PDGF-BB, a major growth factor in serum, induced significant IL-6 production by SSc fibroblasts. In contrast, in normal fibroblasts, much less response to PDGF-BB and almost no response to PDGF-AA were observed. Expression of PDGF receptors on SSc fibroblasts was not significantly different from normal fibroblasts. However, IL-1 receptor antagonist (IL- 1ra), when added in the medium, significantly inhibited the PDGF-induced IL- 6 production by SSc fibroblasts. Conclusion. PDGF stimulates IL-6 production by SSc fibroblasts. The enhanced IL-6 production in response to PDGF is due in part to autocrine IL-1 of SSc fibroblasts. These abnormalities of fibroblasts may play an important role in the inflammatory and immunological processes of SSc.",
keywords = "Fibroblast, Interleukin 6, Platelet derived growth factor, Scleroderma",
author = "Hiroyuki Takemura and Hiroshi Suzuki and Hiroshi Fujisawa and Takamichi Yuhara and Takao Akama and Kazuhide Yamane and Hachiro Kashiwagi",
year = "1998",
month = "8",
language = "English",
volume = "25",
pages = "1534--1539",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "8",

}

TY - JOUR

T1 - Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor

AU - Takemura, Hiroyuki

AU - Suzuki, Hiroshi

AU - Fujisawa, Hiroshi

AU - Yuhara, Takamichi

AU - Akama, Takao

AU - Yamane, Kazuhide

AU - Kashiwagi, Hachiro

PY - 1998/8

Y1 - 1998/8

N2 - Objective. The pathophysiology of systemic sclerosis (SSc) is poorly understood, but recent studies indicate the involvement of cytokines in the functional changes of SSc fibroblasts. We investigated interleukin 6 (IL-6) production by dermal fibroblasts from patients with SSc. Methods. Fibroblast cultures were established from affected skin of patients with SSc and from skin of healthy controls. IL-6 in supernatants from cultured fibroblasts was measured using a specific IL-6 ELISA. Results. SSc fibroblasts, starved in serum-free medium, produced only a small amount of IL-6. However, IL-6 production by SSc fibroblasts dramatically increased when the cells were cultured in serum-containing medium. Human whole blood serum was more effective than human platelet-poor plasma derived serum in the enhancement of IL-6 production by SSc fibroblasts. Platelet derived growth factor (PDGF)-AA and PDGF-BB, a major growth factor in serum, induced significant IL-6 production by SSc fibroblasts. In contrast, in normal fibroblasts, much less response to PDGF-BB and almost no response to PDGF-AA were observed. Expression of PDGF receptors on SSc fibroblasts was not significantly different from normal fibroblasts. However, IL-1 receptor antagonist (IL- 1ra), when added in the medium, significantly inhibited the PDGF-induced IL- 6 production by SSc fibroblasts. Conclusion. PDGF stimulates IL-6 production by SSc fibroblasts. The enhanced IL-6 production in response to PDGF is due in part to autocrine IL-1 of SSc fibroblasts. These abnormalities of fibroblasts may play an important role in the inflammatory and immunological processes of SSc.

AB - Objective. The pathophysiology of systemic sclerosis (SSc) is poorly understood, but recent studies indicate the involvement of cytokines in the functional changes of SSc fibroblasts. We investigated interleukin 6 (IL-6) production by dermal fibroblasts from patients with SSc. Methods. Fibroblast cultures were established from affected skin of patients with SSc and from skin of healthy controls. IL-6 in supernatants from cultured fibroblasts was measured using a specific IL-6 ELISA. Results. SSc fibroblasts, starved in serum-free medium, produced only a small amount of IL-6. However, IL-6 production by SSc fibroblasts dramatically increased when the cells were cultured in serum-containing medium. Human whole blood serum was more effective than human platelet-poor plasma derived serum in the enhancement of IL-6 production by SSc fibroblasts. Platelet derived growth factor (PDGF)-AA and PDGF-BB, a major growth factor in serum, induced significant IL-6 production by SSc fibroblasts. In contrast, in normal fibroblasts, much less response to PDGF-BB and almost no response to PDGF-AA were observed. Expression of PDGF receptors on SSc fibroblasts was not significantly different from normal fibroblasts. However, IL-1 receptor antagonist (IL- 1ra), when added in the medium, significantly inhibited the PDGF-induced IL- 6 production by SSc fibroblasts. Conclusion. PDGF stimulates IL-6 production by SSc fibroblasts. The enhanced IL-6 production in response to PDGF is due in part to autocrine IL-1 of SSc fibroblasts. These abnormalities of fibroblasts may play an important role in the inflammatory and immunological processes of SSc.

KW - Fibroblast

KW - Interleukin 6

KW - Platelet derived growth factor

KW - Scleroderma

UR - http://www.scopus.com/inward/record.url?scp=0031880752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031880752&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 1534

EP - 1539

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 8

ER -